Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 13 June 2019 |
| Author/s |
author: Joyce O'Shaughnessy Lee S Schwartzberg Linda T Vahdat |
| Publication date | June 13, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |